Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Bokemeyer

Showing results (551-560 of 664) with videos related to

Pageof 67
Sort By:
British Journal of Haematology|February 2, 2013
Cytogenetics of extramedullary manifestations in multiple myelomaLisa Billecke, Eva M Murga Penas, Annette M May, et al.
Scientific Reports|May 23, 2024
Synthesis and new DNA targeting activity of 6- and 7-tert-butylfascaplysinsSergey A Dyshlovoy, Wael Y Mansour, Natalia A Ramm, et al.
Medical Oncology (Northwood, London, England)|June 27, 2014
Catumaxomab with and without prednisolone premedication for the treatment of malignant ascites due to epithelial cancer: results of the randomised phase IIIb CASIMAS studyJalid Sehouli, Klaus Pietzner, Pauline Wimberger, et al.
Marine Drugs|December 4, 2020
Efficacy and Mechanism of Action of Marine Alkaloid 3,10-Dibromofascaplysin in Drug-Resistant Prostate Cancer CellsSergey A Dyshlovoy, Moritz Kaune, Jessica Hauschild, et al.
Proteomics|March 23, 2016
Anti-migratory activity of marine alkaloid monanchocidin A - proteomics-based discovery and confirmationSergey A Dyshlovoy, Simone Venz, Jessica Hauschild, et al.
Blood|April 2, 2016
A transplant "immunome" screening platform defines a targetable epitope fingerprint of multiple myelomaAneta Schieferdecker, Anna Oberle, Benjamin Thiele, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2015
Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic EffectsJasmin Wellbrock, Emily Latuske, Julian Köhler, et al.
International Journal of Cancer|June 10, 2026
Plasma PlGF as a Potential Biomarker in Ramucirumab-Based Second-Line Therapy for Advanced Gastroesophageal Adenocarcinoma: Exploratory Biomarker Analysis from the Phase II Part of the RAMIRIS TrialJurek Hille, Sylvie Lorenzen, Claudia Pauligk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancerAlexander T El Gammal, Michael Brüchmann, Jozef Zustin, et al.
Oncoimmunology|April 11, 2018
Dynamic changes of the normal B lymphocyte repertoire in CLL in response to ibrutinib or FCR chemo-immunotherapySimon Schliffke, Mariela Sivina, Ekaterina Kim, et al.
Pageof 67

Showing results (551-560 of 664) with videos related to

Sort By:
Pageof 67
British Journal of Haematology|February 2, 2013
Cytogenetics of extramedullary manifestations in multiple myelomaLisa Billecke, Eva M Murga Penas, Annette M May, et al.
Scientific Reports|May 23, 2024
Synthesis and new DNA targeting activity of 6- and 7-tert-butylfascaplysinsSergey A Dyshlovoy, Wael Y Mansour, Natalia A Ramm, et al.
Medical Oncology (Northwood, London, England)|June 27, 2014
Catumaxomab with and without prednisolone premedication for the treatment of malignant ascites due to epithelial cancer: results of the randomised phase IIIb CASIMAS studyJalid Sehouli, Klaus Pietzner, Pauline Wimberger, et al.
Marine Drugs|December 4, 2020
Efficacy and Mechanism of Action of Marine Alkaloid 3,10-Dibromofascaplysin in Drug-Resistant Prostate Cancer CellsSergey A Dyshlovoy, Moritz Kaune, Jessica Hauschild, et al.
Proteomics|March 23, 2016
Anti-migratory activity of marine alkaloid monanchocidin A - proteomics-based discovery and confirmationSergey A Dyshlovoy, Simone Venz, Jessica Hauschild, et al.
Blood|April 2, 2016
A transplant "immunome" screening platform defines a targetable epitope fingerprint of multiple myelomaAneta Schieferdecker, Anna Oberle, Benjamin Thiele, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2015
Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic EffectsJasmin Wellbrock, Emily Latuske, Julian Köhler, et al.
International Journal of Cancer|June 10, 2026
Plasma PlGF as a Potential Biomarker in Ramucirumab-Based Second-Line Therapy for Advanced Gastroesophageal Adenocarcinoma: Exploratory Biomarker Analysis from the Phase II Part of the RAMIRIS TrialJurek Hille, Sylvie Lorenzen, Claudia Pauligk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancerAlexander T El Gammal, Michael Brüchmann, Jozef Zustin, et al.
Oncoimmunology|April 11, 2018
Dynamic changes of the normal B lymphocyte repertoire in CLL in response to ibrutinib or FCR chemo-immunotherapySimon Schliffke, Mariela Sivina, Ekaterina Kim, et al.
Pageof 67